There exists a risk of research centres situated in the Member States relocating to countries that offer greater protection.
Recital 6, Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009…
Judgment of the Court (Fourth Chamber) of 24 November 2011. Medeva BV v Comptroller General of Patents, Designs and Trade Marks.Decision
Recital 1 and recitals 4 to 10 in the preamble to Regulation No 469/2009 are worded as follows: ‘(1) Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal …
24 Nov 2011 · 62010CJ0322
Judgment of the Court (Fourth Chamber) of 24 November 2011. Georgetown University and Others v Comptroller General of Patents, Designs and TDecision
Recital 1 and recitals 4 to 10 in the preamble to Regulation No 469/2009 are worded as follows: Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products …
24 Nov 2011 · 62010CJ0422
Judgment of the Court (Fourth Chamber), 19 July 2012. Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.Decision
Recitals 1 and 4 to 10 of the SPC Regulation read as follows: Council Regulation (EEC) No 1768/92 … has been substantially amended several times. In the interests of clarity and rationality the said Regulation should be codified. ... At …
19 Jul 2012 · 62011CJ0130
Order of the Court (Fourth Chamber) of 25 November 2011. University of Queensland and CSL Ltd v Comptroller General of Patents, Designs and Decision
Recital 1 and recitals 4 to 10 in the preamble to Regulation No 469/2009 are worded as follows: ‘(1) Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal …
25 Nov 2011 · 62010CO0630
Opinion of Advocate General Saugmandsgaard Øe delivered on 13 December 2018. Abraxis Bioscience LLC v Comptroller General of Patents.Decision
According to recitals 3, 4, 5 and 9 of Regulation No 469/2009, the SPC regime has the purpose of compensating for the lack of protection conferred by a patent with respect to covering the investment put into research concerning new …
13 Dec 2018 · 62017CC0443
Order of the Court (Fourth Chamber) of 25 November 2011. Daiichi Sankyo Company v Comptroller General of Patents, Designs and Trade Marks.Decision
Recital 1 and recitals 4 to 10 in the preamble to Regulation No 469/2009 are worded as follows: Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products …
25 Nov 2011 · 62011CO0006
Order of the Court (Fourth Chamber) of 25 November 2011. Yeda Research and Development Company Ltd and Aventis Holdings Inc. v Comptroller GDecision
Recital 1 and recitals 4 to 10 in the preamble to Regulation No 469/2009 are worded as follows: ‘(1) Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal …
25 Nov 2011 · 62010CO0518
Opinion of Advocate General Pitruzzella delivered on 23 January 2020. Santen SAS v Directeur général de l’Institut national de la propriété Decision
Second, Regulation No 469/2009 seeks to encourage pharmaceutical research by providing for protection to supplement that conferred by the patent, the effective duration of which is reduced because of the time required to obtain an MA …
23 Jan 2020 · 62018CC0673
Judgment of the Court (Second Chamber) of 21 June 2018. Pfizer Ireland Pharmaceuticals, Operations Support Group v Orifarm GmbH.Decision
Thus, it is apparent from recitals 2, 4, 5 and 6 of the SPC Regulation that the continuing improvement in public health through research is the main concern of the EU legislature. In the same vein, Regulation No 1901/2006 aims, according …
21 Jun 2018 · 62016CJ0681